Skip to content

Time-Restricted Eating to Address Persistent Cancer-Related Fatigue

Time-Restricted Eating to Address Persistent Cancer-Related Fatigue: The Fatigue REDuction After Cancer (FREDA) Trial

Status
Active, not recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05256888
Enrollment
50
Registered
2022-02-25
Start date
2023-01-26
Completion date
2026-04-30
Last updated
2025-05-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Neoplasms, Therapy, Fatigue, Diet Therapy, Time, Survivorship, Fasting, Intermittent

Brief summary

This study will assess the feasibility of delivering a 12-week time-restricted eating intervention as well as the intervention's preliminary efficacy on persistent cancer-related fatigue among cancer survivors compared to a general health education control. Participants will be randomized 1:1 to one of two arms: time-restricted eating or control. Those in the intervention arm will self-select a 10-hour eating window in which to consume all food and beverages (water is allowed any time, black coffee and unsweetened tea are allowed in the morning). Both groups will receive weekly educational tips on healthy lifestyle behaviors in cancer survivorship. This study will also explore relationships between fatigue, circadian rhythm, and glucose metabolism. The hypothesis is that recruitment will be feasible, and participants will adhere to time-restricted eating and complete study activities over the course of the 12 weeks. The second hypothesis is that time-restricted eating will lead to less fatigue at 12 weeks compared to the control, accounting for baseline fatigue levels.

Interventions

BEHAVIORALTime-restricted eating

12 weeks of time-restricted eating (10-hour window)

Weekly tips on healthy lifestyle behaviors (e.g., diet, exercise, sleep) for 12 weeks

Sponsors

National Center for Advancing Translational Sciences (NCATS)
CollaboratorNIH
University of Maryland, Baltimore
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Have completed adjuvant chemotherapy, surgery, and/or radiation for cancer, including chemotherapy for hematologic neoplasms, at least 2 months and not more than 2 years prior to enrolling, * Have a baseline level of fatigue, as determined by reporting a score of 4 or higher for the question, In the last week, how bad was your worst fatigue on a scale from 0-10? * Be able to speak and/or read and write in English, * Be at least 18 years old, * Own a smartphone, * Be willing and able to adhere to study procedures, including use of a smartphone app, and * Be able to provide informed consent.

Exclusion criteria

* Already eat all their food within a window that is 10 h or shorter most (6/7) days of the week, * Be underweight, as defined as a body mass index ≤18.5 kg/m2, * Have surgery planned during the study duration, * Have any contraindications to the proposed nutrition intervention as identified by their medical provider, their designee, or the study team (e.g., type 1 diabetes, risk for hypoglycemia, medication requirements, pregnancy, breastfeeding, recent history of an eating disorder), * Be taking insulin, or * Be on enteral or parenteral nutrition.

Design outcomes

Primary

MeasureTime frameDescription
Feasibility, as Assessed by the Percentage of Participants Who Enrolled Completed the Study12 weeksTo assess feasibility, the percentage of participants who provide evaluable data regarding their eating window at baseline and 12 weeks will be assessed.
Fatigue, as Assessed Using the Functional Assessment of Chronic Illness Therapy-Fatigue (FACIT-F) Questionnaire12 weeksFACIT-F fatigue subscale scores will be compared for those in the time-restricted eating group vs. the control group at week 12, controlling for baseline levels. This questionnaire is 13-items long. The scale is from 0-52, and a higher score indicates less fatigue.

Countries

United States

Participant flow

Pre-assignment details

Participants must have completed baseline assessments, including the FACIT-F questionnaire, in order to be randomized. There were 20 people who consented to the study but did not complete baseline assessments and therefore were not randomized to an arm.

Participants by arm

ArmCount
Time-restricted Eating
Participants will self-select a 10-hour window in which to consume all food and beverages (with the exception of black coffee and unsweetened tea in the mornings; water is okay at all times). Participants will also receive weekly tips to encourage a healthy lifestyle in cancer survivorship. Time-restricted eating: 12 weeks of time-restricted eating (10-hour window) Healthy lifestyle education: Weekly tips on healthy lifestyle behaviors (e.g., diet, exercise, sleep) for 12 weeks
15
Control
Participants will receive weekly tips to encourage healthy lifestyle behaviors in cancer survivorship. Healthy lifestyle education: Weekly tips on healthy lifestyle behaviors (e.g., diet, exercise, sleep) for 12 weeks
15
Total30

Baseline characteristics

CharacteristicTime-restricted EatingTotalControl
Age, Continuous54.6 years
STANDARD_DEVIATION 12.7
54.1 years
STANDARD_DEVIATION 14.7
53.7 years
STANDARD_DEVIATION 16.8
Ethnicity (NIH/OMB)
Hispanic or Latino
2 Participants2 Participants0 Participants
Ethnicity (NIH/OMB)
Not Hispanic or Latino
13 Participants28 Participants15 Participants
Ethnicity (NIH/OMB)
Unknown or Not Reported
0 Participants0 Participants0 Participants
Race (NIH/OMB)
American Indian or Alaska Native
0 Participants0 Participants0 Participants
Race (NIH/OMB)
Asian
0 Participants0 Participants0 Participants
Race (NIH/OMB)
Black or African American
10 Participants16 Participants6 Participants
Race (NIH/OMB)
More than one race
0 Participants1 Participants1 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
0 Participants0 Participants0 Participants
Race (NIH/OMB)
Unknown or Not Reported
0 Participants0 Participants0 Participants
Race (NIH/OMB)
White
5 Participants13 Participants8 Participants
Region of Enrollment
United States
15 participants30 participants15 participants
Sex: Female, Male
Female
13 Participants23 Participants10 Participants
Sex: Female, Male
Male
2 Participants7 Participants5 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
0 / 150 / 15
other
Total, other adverse events
1 / 150 / 15
serious
Total, serious adverse events
0 / 152 / 15

Outcome results

Primary

Fatigue, as Assessed Using the Functional Assessment of Chronic Illness Therapy-Fatigue (FACIT-F) Questionnaire

FACIT-F fatigue subscale scores will be compared for those in the time-restricted eating group vs. the control group at week 12, controlling for baseline levels. This questionnaire is 13-items long. The scale is from 0-52, and a higher score indicates less fatigue.

Time frame: 12 weeks

ArmMeasureValue (MEAN)Dispersion
All ParticipantsFatigue, as Assessed Using the Functional Assessment of Chronic Illness Therapy-Fatigue (FACIT-F) Questionnaire38.7 score on a scaleStandard Deviation 9.2
ControlFatigue, as Assessed Using the Functional Assessment of Chronic Illness Therapy-Fatigue (FACIT-F) Questionnaire37.2 score on a scaleStandard Deviation 9.1
Comparison: In a linear model to assess group effects on fatigue at 12 weeks, adjusting for baseline levels of fatigue:~Effect of group = -1.77±1.08, p=0.11, favoring the TRE group.p-value: 0.11Regression, Linear
Primary

Feasibility, as Assessed by the Percentage of Participants Who Enrolled Completed the Study

To assess feasibility, the percentage of participants who provide evaluable data regarding their eating window at baseline and 12 weeks will be assessed.

Time frame: 12 weeks

ArmMeasureValue (COUNT_OF_PARTICIPANTS)
All ParticipantsFeasibility, as Assessed by the Percentage of Participants Who Enrolled Completed the Study25 Participants

Source: ClinicalTrials.gov · Data processed: Feb 5, 2026